Head to Head Analysis: Venus Concept (NASDAQ:VERO) vs. Mobia Medical (NASDAQ:MOBI)

Mobia Medical (NASDAQ:MOBI) and Venus Concept (NASDAQ:VERO) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Valuation and Earnings

This table compares Mobia Medical and Venus Concept”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mobia Medical	$32.04 million	11.02	-$46.50 million	($20.18)	-0.53
Venus Concept	$58.88 million	0.01	-$47.00 million	($48.84)	-0.01

Mobia Medical has higher earnings, but lower revenue than Venus Concept. Mobia Medical is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Mobia Medical and Venus Concept’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mobia Medical	N/A	N/A	N/A
Venus Concept	-92.76%	-1,904.25%	-85.22%

Analyst Ratings

This is a summary of current recommendations and price targets for Mobia Medical and Venus Concept, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mobia Medical	1	1	5	0	2.57
Venus Concept	1	0	0	0	1.00

Mobia Medical presently has a consensus target price of $20.75, suggesting a potential upside of 95.57%. Given Mobia Medical’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Mobia Medical is more favorable than Venus Concept.

Insider and Institutional Ownership

87.4% of Venus Concept shares are owned by institutional investors. 28.0% of Venus Concept shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Mobia Medical beats Venus Concept on 9 of the 13 factors compared between the two stocks.

About Mobia Medical

Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.

About Venus Concept

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.